Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
NOF

NOF

NOF supplies the high-purity phospholipid, phospholipid derivatives and liposome for pharmaceuticals. Using state-of-the-art synthesis and purification technology, we have developed various kinds and grades of products. Bulk phospholipids are produced in the facility under GMP operation and have been supplied worldwide for many years with good reputation. NOF supplies purified egg PC, egg PG, soy PC, hydrogenated soy PC and sphingomyelin for natural phospholipids. Regarding synthetic phospholipid, DDPC, DLPC, DMPC, DPPC, DSPC, DOPC, POPC and DEPC are available for PC series. DMPG, DPPG, DSPG, POPG are available for PG series. DMPA, DPPA and DSPA are available for PA series. DMPE, DPPE, DSPE and DOPE are available for PE series. DOPS is available for PS series in stock. PEG or polyglycerin attached phospholipid (PEG phospholipid) are available for long circulating liposome formulation. Activated functional group attached phospholipid either PEG end or non PEG end are also available for immunoliposome or targeting use liposome. For non injectable use, DPPC, POPC and POPG are recommended for pulmonary delivery while DOPC, POPC and DDPC are recommended for nasal delivery. We also offer custom-made synthesis of phospholipid and provide unique liposome research kit (Empty liposome) for drug delivery systems (DDS). Furthermore, small and large scale equipments for liposome production are available from NOF.

Last updated on

About NOF

Estimated Revenue

$1B-$10B

Employees

1K-5K

Category

Industry

Chemicals

Location

City

Hirayama

State

Shizuoka

Country

Japan
NOF

NOF

Find your buyer within NOF

Tech Stack (0)

search